AI assistant
Sending…
RESMED INC — Director's Dealing 2016
Nov 18, 2016
30071_dirs_2016-11-18_8ca05911-7859-4771-b62a-5c3ba9fd4e57.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2016-11-16
Reporting Person: ROBERTS CHRISTOPHER G (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2016-11-16 | ResMed Common Stock Options | $57.76 | A | 23277 | Acquired | 2023-11-16 | ResMed Common Stock (23277) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| ResMed Common Stock | 145610 | Direct |
| ResMed Common Stock | 323900 | Indirect |
| ResMed Common Stock | 136000 | Indirect |
| ResMed Common Stock | 23200 | Indirect |
Footnotes
F1: Options vest in full on the first November 11 following the grant date, or the first annual shareholders meeting following grant date.
More from RESMED INC
Regulatory Filings
2026
May 26
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 10
Regulatory Filings
2026
Feb 9
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 3
Interim / Quarterly Report
2026
Jan 30
Earnings Release
2026
Jan 29